Simon Travis

42.7k total citations · 14 hit papers
433 papers, 21.8k citations indexed

About

Simon Travis is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Simon Travis has authored 433 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 302 papers in Genetics, 257 papers in Epidemiology and 147 papers in Surgery. Recurrent topics in Simon Travis's work include Inflammatory Bowel Disease (292 papers), Microscopic Colitis (225 papers) and Eosinophilic Esophagitis (40 papers). Simon Travis is often cited by papers focused on Inflammatory Bowel Disease (292 papers), Microscopic Colitis (225 papers) and Eosinophilic Esophagitis (40 papers). Simon Travis collaborates with scholars based in United Kingdom, United States and Canada. Simon Travis's co-authors include Gert Van Assche, Axel Dignaß, Markus F. Neurath, Eduard F. Stange, Walter Reinisch, Gerassimos J. Mantzaris, James O. Lindsay, Robert V. Bryant, Alissa Walsh and Bryan F. Warren and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Simon Travis

405 papers receiving 21.3k citations

Hit Papers

Second European evidence-based consensu... 1996 2026 2006 2016 2012 2012 2010 2010 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
    2012 1.2k citations Walter Reinisch, Eduard F. Stange et al. Journal of Crohn s and Colitis profile →
  2. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
    2012 1.2k citations Wolfgang Hueber, Bruce E. Sands et al. Gut profile →
  3. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
    2010 1.1k citations Silvio Danese, Eduard F. Stange et al. Journal of Crohn s and Colitis profile →
  4. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
    2010 1.0k citations Julián Panés, Édouard Louis et al. Journal of Crohn s and Colitis profile →
  5. Mucosal healing in inflammatory bowel diseases: a systematic review
    2012 640 citations Simon Travis et al. Gut profile →
  6. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
    2012 638 citations Walter Reinisch, Simon Travis et al. Journal of Crohn s and Colitis profile →
  7. Predicting outcome in severe ulcerative colitis.
    1996 539 citations Simon Travis et al. Gut profile →
  8. IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
    2011 514 citations Simon Travis et al. profile →
  9. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit
    2011 449 citations Sarah Hearnshaw, Simon Travis et al. Gut profile →
  10. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)
    2011 441 citations Simon Travis, Brian G. Feagan et al. Gut profile →
  11. The Diagnostic Approach to Monogenic Very Early Onset Inflammatory Bowel Disease
    2014 437 citations Holm H. Uhlig, Tobias Schwerd et al. profile →
  12. Development and validation of the Nancy histological index for UC
    2015 303 citations Aude Marchal-Bressenot, Julia Salleron et al. Gut profile →
  13. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up
    2015 300 citations Robert V. Bryant, Alissa Walsh et al. Gut profile →
  14. Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
    2020 179 citations Simon Travis et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Travis United Kingdom 67 14.9k 11.7k 7.5k 3.8k 2.6k 433 21.8k
Walter Reinisch Austria 57 14.1k 0.9× 11.0k 0.9× 5.3k 0.7× 4.0k 1.1× 2.0k 0.8× 340 19.9k
Stephen B. Hanauer United States 66 19.1k 1.3× 14.5k 1.2× 6.3k 0.8× 5.9k 1.6× 1.8k 0.7× 412 24.7k
Julián Panés Spain 84 14.2k 0.9× 11.2k 1.0× 8.5k 1.1× 4.8k 1.3× 1.8k 0.7× 590 26.0k
Anne M. Griffiths Canada 77 16.1k 1.1× 11.3k 1.0× 7.3k 1.0× 3.6k 1.0× 1.6k 0.6× 363 23.0k
William J. Tremaine United States 70 13.7k 0.9× 11.0k 0.9× 7.2k 1.0× 2.0k 0.5× 2.1k 0.8× 268 19.3k
David T. Rubin United States 64 11.1k 0.7× 8.5k 0.7× 5.1k 0.7× 2.3k 0.6× 1.9k 0.7× 727 18.1k
Axel Dignaß Germany 55 10.1k 0.7× 7.1k 0.6× 5.1k 0.7× 2.7k 0.7× 1.2k 0.5× 282 17.3k
Marc Ferrante Belgium 64 12.4k 0.8× 8.9k 0.8× 5.3k 0.7× 4.7k 1.3× 1.6k 0.6× 543 21.4k
Daniel H. Present United States 48 13.5k 0.9× 10.1k 0.9× 5.4k 0.7× 4.0k 1.1× 1.1k 0.4× 135 17.9k
Edward V. Loftus United States 98 26.3k 1.8× 21.5k 1.8× 13.7k 1.8× 4.8k 1.3× 3.4k 1.3× 773 37.2k

Countries citing papers authored by Simon Travis

Since Specialization
Citations

This map shows the geographic impact of Simon Travis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Travis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Travis more than expected).

Fields of papers citing papers by Simon Travis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Travis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Travis. The network helps show where Simon Travis may publish in the future.

Co-authorship network of co-authors of Simon Travis

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Travis. A scholar is included among the top collaborators of Simon Travis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Travis. Simon Travis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jairath, Vipul, Geert D’Haens, Bruce E. Sands, et al.. (2025). Bowel Urgency in Crohn’s Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study. Clinical Gastroenterology and Hepatology. 24(2). 463–473.e5.
2.
Jairath, Vipul, Brian G. Feagan, Mark S. Silverberg, et al.. (2024). Mucosal Healing With Vedolizumab in Patients With Chronic Pouchitis: EARNEST, a Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Gastroenterology and Hepatology. 23(2). 321–330.e3. 1 indexed citations
3.
Cates, Angharad N. de, Catherine J. Harmer, Paul J. Harrison, et al.. (2024). Association between a selective 5-HT4 receptor agonist and incidence of major depressive disorder: emulated target trial. The British Journal of Psychiatry. 225(3). 371–378. 4 indexed citations
4.
East, James E., et al.. (2023). Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions. Intestinal Research. 21(3). 283–294. 23 indexed citations
5.
Travis, Simon, Mark S. Silverberg, Silvio Danese, et al.. (2023). Vedolizumab for the Treatment of Chronic Pouchitis. New England Journal of Medicine. 388(13). 1191–1200. 58 indexed citations
6.
Louis, Édouard, Antonino Spinelli, Simon Travis, et al.. (2023). The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease. Crohn s & Colitis 360. 5(2). otad006–otad006. 6 indexed citations
7.
8.
Adams, Alex, Vipin Gupta, Thomas Chapman, et al.. (2021). OFR-10 Admission model for intensification of therapy in acute severe colitis (ADMIT-ASC). Griffith Research Online (Griffith University, Queensland, Australia). A4.2–A5. 1 indexed citations
9.
Uhlig, Holm H., Fabienne Charbit‐Henrion, Daniel Kotlarz, et al.. (2020). Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 72(3). 456–473. 79 indexed citations
10.
Das, Bhabatosh, Tarini Shankar Ghosh, Saurabh Kedia, et al.. (2018). Analysis of the Gut Microbiome of Rural and Urban Healthy Indians Living in Sea Level and High Altitude Areas. Scientific Reports. 8(1). 10104–10104. 109 indexed citations
11.
Vuitton, Lucine, Laurent Peyrin‐Biroulet, J.F. Colombel, et al.. (2017). Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus. Alimentary Pharmacology & Therapeutics. 45(6). 801–813. 102 indexed citations
12.
Bryant, Robert V., Samuel P. Costello, Scott Schoeman, et al.. (2017). Limited uptake of ulcerative colitis “treat‐to‐target” recommendations in real‐world practice. Journal of Gastroenterology and Hepatology. 33(3). 599–607. 35 indexed citations
13.
Bye, William A., Vipul Jairath, & Simon Travis. (2017). Systematic review: the safety of vedolizumab for the treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 46(1). 3–15. 78 indexed citations
14.
Marchal-Bressenot, Aude, Julia Salleron, Camille Boulagnon‐Rombi, et al.. (2015). Development and validation of the Nancy histological index for UC. Gut. 66(1). 43–49. 303 indexed citations breakdown →
15.
Bryant, Robert V., Shawn Winer, Simon Travis, & Robert H. Riddell. (2014). Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiative. Journal of Crohn s and Colitis. 8(12). 1582–1597. 219 indexed citations
16.
Hueber, Wolfgang, Bruce E. Sands, Steve Lewitzky, et al.. (2012). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 61(12). 1693–1700. 1156 indexed citations breakdown →
17.
Leedham, Simon J., Pedro Rodenas-Cuadrado, Kimberley Howarth, et al.. (2012). A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts. Gut. 62(1). 83–93. 69 indexed citations
18.
Jairath, Vipul, et al.. (2010). Early coagulopathy is associated with increased mortality and re-bleeding in non-cirrhotics with acute upper gastrointestinal bleeding. British Journal of Haematology. 149. 5–5. 2 indexed citations
19.
Stange, Eduard F. & Simon Travis. (2008). The European consensus on ulcerative colitis: new horizons?: Table 1. Gut. 57(8). 1029–1031. 17 indexed citations
20.
Travis, Simon. (1998). Clinicians’ Guide to Inflammatory Bowel Disease. Gut. 42(3). 448.5–448. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter Reinisch Breakdown of academic impact, for papers by Stephen B. Hanauer Breakdown of academic impact, for papers by Julián Panés Breakdown of academic impact, for papers by Anne M. Griffiths Breakdown of academic impact, for papers by William J. Tremaine Breakdown of academic impact, for papers by David T. Rubin Breakdown of academic impact, for papers by Axel Dignaß Breakdown of academic impact, for papers by Marc Ferrante Breakdown of academic impact, for papers by Daniel H. Present Breakdown of academic impact, for papers by Edward V. Loftus
Rankless by CCL
2026